Vialwirebiotech, curated
November 21, 2026, 8:02 AM
October 20, 2026
- 9:00 AM · BioWorld9:00 AMExeliris and Lin Gang Laboratory describe new GluN2B and SERT inhibitors — BioWorld
- 9:00 AM · Labiotech (EU)9:00 AMNovo’s pipeline in 2026: A new plan to reach $23 billion in sales by 2035 — Labiotech (EU)
- 9:00 AM · BioWorld
- 9:00 AM · BioWorld9:00 AMAtyr collaborates to study ATYR-2810 in pediatric osteosarcoma — BioWorld
- 9:00 AM · BioWorld9:00 AMShenzhen Zhongge Biotechnology patents new SARM1 inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMEnsem Therapeutics discloses new PI3Kα inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMNIH supports Up Oncolytics’ oncolytic virotherapy for glioblastoma — BioWorld
- 9:00 AM · BioWorld9:00 AMShanghai Qilu Pharmaceutical identifies new LIV-1-targeting ADCs — BioWorld
- 8:47 AM · Drug Discovery World8:47 AMCarnyx Therapeutics unveils oral sleep candidate — Drug Discovery World
- 12:00 AM · SCMP — Tech12:00 AMChina’s new 0.1-nanometre electron microscope ready to challenge US and Japan — SCMP — Tech
October 19, 2026
- 12:19 PM · SCMP — Tech
- 12:00 PM · BioWorld12:00 PMG2Gbio lands United Bio deal for microsphere injectable tech — BioWorld
- 12:00 PM · BioWorld12:00 PMEyepoint sinks, cuts workforce, on second phase III AMD failure — BioWorld
- 12:00 PM · Bloomberg — Technology12:00 PMBiotech Firm Colossal Set to Return Extinct Bird’s Egg to New Zealand — Bloomberg — Technology
- 12:00 PM · BioWorld12:00 PMNouscom raises €120M series D for cancer vaccine pivotal trial — BioWorld
- 9:59 AM · BioPharma Dive9:59 AMMerck KGaA bets on RNAi with $1.3B Silence buyout — BioPharma Dive
- 9:00 AM · BioWorld9:00 AMChipscreen’s NW-001 cleared for clinic in China — BioWorld
- 9:00 AM · BioWorld
- 9:00 AM · BioWorld9:00 AMZymeworks identifies new PTK7-targeting antibody-drug conjugates — BioWorld
- 9:00 AM · BioWorld9:00 AMApini’s eNAMPT inhibitor improves colitis phenotype in mice — BioWorld
- 7:00 AM · Drug Discovery World7:00 AMMission doses first Parkinson’s patient in Phase Ib study — Drug Discovery World
- 5:41 AM · Pharmaceutical Technology5:41 AMFDA approves Viatris’ Ryzumvi for adult presbyopia — Pharmaceutical Technology
- 5:00 AM · Drug Discovery World5:00 AMInitial data from Phase I/II trial of base editing therapy at ESGCT — Drug Discovery World
- 5:00 AM · BioPharma Dive5:00 AMFrom strategy to scale: How Saudi Arabia is building a biotech ecosystem — BioPharma Dive
- 4:35 AM · STAT News